2023. Evaluating Fluoxetine’s Growth-Inhibitory Impact on Clinical Isolates of Enteric Bacteria: Harnessing Repurposing Potential. Microbiological & Immunological Communications. 2, 2 (Dec. 2023), 89–96. DOI:https://doi.org/10.55627/mic.002.02.0454.